您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > Desipramine-d4(hydrochloride)
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Desipramine-d4(hydrochloride)
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Desipramine-d4(hydrochloride)图片
CAS NO:61361-34-0
包装与价格:
包装价格(元)
500 µg电议
1mg电议
5mg电议

产品介绍
An internal standard for the quantification of desipramine
Cas No.61361-34-0
别名盐酸去郁敏D4
Canonical SMILESCNCCCN1C2=C([2H])C=C([2H])C=C2CCC3=CC([2H])=CC([2H])=C31.Cl
分子式C18H18D4N2 • HCl
分子量306.9
溶解度Water: soluble
储存条件-20°C
General tipsFor obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping ConditionEvaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request
产品描述

Desipramine-d4is intended for use as an internal standard for the quantification of desipramine by GC- or LC-MS. Desipramine is a tricyclic antidepressant and an active metabolite of imipramine .1It inhibits the serotonin (5-HT) and norepinephrine transporters (Kis = 163 and 3.5 nM for human SERT and NET, respectively) and is an antagonist of the 5-HT receptor subtype 5-HT2Aand the α1-adrenergic receptor (α1-AR), as well as histamine H1and muscarinic acetylcholine receptors (mAChRs; Kis = 115, 23, 31, and 37 nM, respectively). Desipramine is selective for the 5-HT2Areceptor over the 5-HT1Areceptor (Ki= 2,272 nM) and for α1-AR over α2-AR (Ki= 1,379 nM). It also selectively inhibits G protein-activated inward rectifier potassium channel (GIRK), also known as Kir3, currents inXenopusoocytes expressing human GIRK1 and GIRK2 or human GIRK1 and GIRK4 (IC50s = 36.4 and 53.9 µM, respectively) over Kir1.1 or Kir2.1 currents inXenopusoocytes expressing the human channels (IC50s = >100 µM for both).2Desipramine (3.2 mg/kg) decreases immobility time in the forced swim test in mice.3It also decreases flinching, as well as paw biting and licking, in the second phase of the formalin test in rats.4Formulations containing desipramine have been used in the treatment of depression.

1.Owens, M.J., Neal, W., Plott, S.J., et al.Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolitesJ. Pharmacol. Exp. Ther.283(3)1305-1322(1997) 2.Kobayashi, T., Washiyama, K., and Ikeda, K.Inhibition of G protein-activated inwardly rectifying K+ channels by various antidepressant drugsNeuropsychopharmacology29(10)1841-1851(2004) 3.Koek, W., Sandoval, T.L., and Daws, L.C.Effects of the antidepressants desipramine and fluvoxamine on latency to immobility and duration of immobility in the forced swim test in adult male C57BL/6J miceBehav. Pharmacol.29(5)453-456(2018) 4.Swaynok, J., Esser, M.J., and Reid, A.R.Peripheral antinociceptive actions of desipramine and fluoxetine in an inflammatory and neuropathic pain test in the ratPain82(2)149-158(1999)